Incyte INCY
$114.63 −$1.25 (-1.07%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $114.63 0.00%
Open$116.85
Prev close$115.87
Day range$114.28 – $117.51
Volume1.54M
Market cap$23.36B
P/E (TTM)58.5
Dividend yield–
INCY Stock News
Headlines matching Incyte or the INCY ticker, most recent first.
- H.C. Wainwright Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $152
- HC Wainwright & Co. Maintains Buy on Incyte, Raises Price Target to $152 Positive
- H.C. Wainwright Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $152 Positive
- H.C. Wainwright Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $150
- BMO Capital Maintains Incyte(INCY.US) With Hold Rating, Maintains Target Price $130
- HC Wainwright & Co. Reiterates Buy on Incyte, Maintains $150 Price Target
- Mizuho Securities Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $137 Positive
- Leerink Partners Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $155 Positive
- CCORF Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $152
- CCORF Initiates Incyte(INCY.US) With Buy Rating, Announces Target Price $152
- William Blair Maintains Incyte(INCY.US) With Hold Rating
- Piper Sandler Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $130 Positive
- H.C. Wainwright Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $150 Positive
- 4: Incyte | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LP
- BMO Capital Upgrades Incyte(INCY.US) to Hold Rating, Raises Target Price to $130 Positive
No comments yet — be the first to weigh in on INCY.
Sign in to join the discussion.